Evidence map›Paper›PMID 29371201›Full record

ArticleJournal of the American Heart Association2018

Nonmuscle Myosin Light Chain Kinase: A Key Player in Intermittent Hypoxia-Induced Vascular Alterations.

Claire Arnaud, Sophie Bouyon, Sylvain Recoquillon, Sandrine Brasseur, Emeline Lemarié, Anne Briançon-Marjollet, Brigitte Gonthier, Marta Toral, Gilles Faury, M Carmen Martinez and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Claire ArnaudLaboratoire HP2, Université Grenoble Alpes, Grenoble, France claire.arnaud@univ-grenoble-alpes.fr.
Sophie BouyonLaboratoire HP2, Université Grenoble Alpes, Grenoble, France.
Sylvain RecoquillonUniversité d'Angers Université Bretagne Loire, Angers, France.
Sandrine BrasseurLaboratoire HP2, Université Grenoble Alpes, Grenoble, France.
Emeline LemariéLaboratoire HP2, Université Grenoble Alpes, Grenoble, France.
Anne Briançon-MarjolletLaboratoire HP2, Université Grenoble Alpes, Grenoble, France.
Brigitte GonthierLaboratoire HP2, Université Grenoble Alpes, Grenoble, France.
Marta ToralUniversité d'Angers Université Bretagne Loire, Angers, France.
Gilles FauryLaboratoire HP2, Université Grenoble Alpes, Grenoble, France.
M Carmen MartinezUniversité d'Angers Université Bretagne Loire, Angers, France.
Ramaroson AndriantsitohainaUniversité d'Angers Université Bretagne Loire, Angers, France.
Jean-Louis PepinLaboratoire HP2, Université Grenoble Alpes, Grenoble, France.
Inserm · FRUniversité Grenoble Alpes · FRUniversité Bretagne Loire · FRCentre Hospitalier Universitaire de Grenoble · FRUniversité d'Angers · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObstructive sleep apnea is characterized by repetitive pharyngeal collapses during sleep, leading to intermittent hypoxia (IH), the main contributor of obstructive sleep apnea-related cardiovascular morbidity. In patients and rodents with obstructive sleep apnea exposed to IH, vascular inflammation and remodeling, endothelial dysfunction, and circulating inflammatory markers are linked with IH severity. The nonmuscle myosin light chain kinase (nmMLCK) isoform contributes to vascular inflammation and oxidative stress in different cardiovascular and inflammatory diseases. Thus, in the present study, we hypothesized that nmMLCK plays a key role in the IH-induced vascular dysfunctions and inflammatory remodeling. METHODS AND

resultsTwelve-week-old nmMLCK

conclusionsnmMLCK is a key mechanism in IH-induced vascular oxidative stress and inflammation and both functional and structural remodeling.

Indexed as

AnimalsArterial PressureArteriesCell LineDisease Models, AnimalElectric ImpedanceHypoxiaInflammation MediatorsMaleMice, Inbred C57BLMice, KnockoutMyosin-Light-Chain KinaseNitric OxideOxidative StressSignal TransductionVascular DiseasesInflammation MediatorsMyosin-Light-Chain KinaseNitric Oxidenon-muscle myosin light-chain kinase, mousehigh blood pressurehypertensionhypoxiainflammationmyosin light chain kinaseobstructive sleep apneaoxidative stressvascular remodeling

Identifiers

PMID29371201
PMCPMC5850262
OpenAlexW2787922396

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.